NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Prudentia Sciences

Prudentia Sciences

Private
Cambridge, MassachusettsEnterprise Softwarehttps://www.prudentiasciences.com/

Last Round

Series A

Jan 7, 2026

Total Funding Raised

$34M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Prudentia Sciences is a business/productivity software company that provides an AI-native platform for due diligence, valuation, and dealmaking for the life sciences industry.

Sector

Enterprise Software

Verticals

Biotechnology, Drug Discovery, Business Intelligence, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

life sciences dealmakingdrug asset valuationscientific due diligencebiotech deal intelligencevertical SaaSpharma M&AAI-native platformdrug development dataclinical strategydeal intelligencebiotech investingpharma deal flowbiotech deal flowbiotech softwarepharma software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prudentia Sciences Comparables

Compare Prudentia Sciences with similar companies based on industry and business-model similarity.

Prudentia Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
One Zyme
88%
SNAP Life Sciences
86%
PhaseFolio
80%

Prudentia Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 7, 2026
SeedJan 9, 2025

Key People

Founding team and executive leadership

Sadiqa Mahmood

CEO Founder

Founding Team

John Reynders

Chief Technology Officer

Executive Team

Sean O'Shea

CTO

Executive Team

Prudentia Sciences Investors

Notable investors and investment history

Prudentia Sciences investors
InvestorRounds
Iaso VenturesSeries A, Seed
GVSeries A, Seed
McKesson VenturesSeries A
McKesson VenturesSeries A
SignalFireSeries A
VirtueSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 25, 2026

    Grew 40% QoQ, from 15 to 21 employees.

  • Jan 7, 2026

    $20M round completed.

Prudentia Sciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Prudentia Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Prudentia Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range21
Year Founded2023
Last FundingJan 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.